How we treat NK/T-cell lymphomas

E Tse, WL Zhao, J **ong, YL Kwong - Journal of hematology & oncology, 2022 - Springer
Abstract Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a
predilection for Asian and South American populations. Epstein–Barr virus (EBV) infection in …

The diagnosis and management of NK/T-cell lymphomas

E Tse, YL Kwong - Journal of hematology & oncology, 2017 - Springer
Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignancy of putative NK-
cell origin, with a minority deriving from the T-cell lineage. Pathologically, the malignancy …

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

YL Kwong, TSY Chan, D Tan, SJ Kim… - Blood, The Journal …, 2017 - ashpublications.org
Abstract Natural killer (NK)/T-cell lymphomas failing L-asparaginse regimens have no
known salvage and are almost invariably fatal. Seven male patients with NK/T-cell …

NK-/T-cell lymphomas

H Wang, B Fu, RP Gale, Y Liang - Leukemia, 2021 - nature.com
Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein–Barr virus (EBV)-related non-
Hodgkin lymphomas common in Asia and Latin America but rare elsewhere. Its …

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas

SF Barrington, R Kluge - European journal of nuclear medicine and …, 2017 - Springer
Abstract PET using 18 F-FDG for treatment monitoring in patients with lymphoma is one of
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …

Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type

M Yamaguchi, R Suzuki… - Blood, The Journal of the …, 2018 - ashpublications.org
Extranodal natural killer/T-cell lymphoma, nasal type (ENKL) is a subtype of mature T-and
natural killer cell lymphomas characterized by its association with Epstein-Barr virus and …

Extranodal NK/T cell lymphoma, nasal type: an updated overview

C Sanchez-Romero, R Bologna-Molina… - Critical Reviews in …, 2021 - Elsevier
Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) is an aggressive malignancy
associated with Epstein-Barr virus infection, with a geographic and racial predilection for …

[HTML][HTML] Comparison of efficacy of pembrolizumab between epstein-barr virus‒positive and‒negative relapsed or refractory non-hodgkin lymphomas

SJ Kim, J Hyeon, I Cho, YH Ko, WS Kim - Cancer Res Treat, 2019 - synapse.koreamed.org
Purpose Pembrolizumab, a programmed cell death protein 1 (PD1) inhibitor inhibits the
interplay between PD1 of T-cell and programmed cell death ligand 1 (PDL1) on tumor cells …

Diagnosis and management of extranodal NK/T cell lymphoma nasal type

E Tse, YL Kwong - Expert Review of Hematology, 2016 - Taylor & Francis
ABSTRACT Introduction: Extranodal NK/T-cell lymphoma nasal type is a distinct
clinicopathologic entity. The most common initial site of presentation is the nasopharyngeal …

[HTML][HTML] Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)

AS Cottereau, S Becker, F Broussais, O Casasnovas… - Annals of …, 2016 - Elsevier
Background Most peripheral T-cell lymphoma (PTCL) patients have a poor outcome and the
identification of prognostic factors at diagnosis is needed. Patients and methods The …